Cvrx, Inc.
A maker of implantable medical devices, CVRx builds Barostim, a tiny device that sits under the skin and gently pulses the body's own carotid baroreceptors to ease the symptoms of heart failure — the first device of its kind approved by the FDA. Founded in 2001 by two engineers, it took its name from a mashup of "cardiovascular" and "Rx," the shorthand for prescription or therapy.
Granted 8.7K
Granted 8.7K
Sold 7.8K
Sold 1.7K
Sold 4.0K
Sold 1.3K
Sold 1.3K
Granted 8.7K
Granted 34.0K
Granted 29.0K
Granted 8.7K
Granted 8.7K
Granted 8.7K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Nielsen Kirk G.Director · 1 transaction | — | 1.92M | 8.7K | — | — |
| Jain Mudit K.Director · 1 transaction | +0.9% | 994.6K | 8.7K | — | — |
| Hykes KevinPRES & CEO, Director · 1 transaction | -2.7% | 284.2K | — | — | 7.8K |
| Oasheim JaredCHIEF FINANCIAL OFFICER · 1 transaction | -1.8% | 96.7K | — | — | 1.7K |
| John Robert AllenChief Revenue Officer · 1 transaction | -4.4% | 86.0K | — | — | 4.0K |
| Adamson Philip B.Chief Medical Officer · 1 transaction | -2% | 61.6K | — | — | 1.3K |
| Verrastro PaulCHIEF MKTG & STRAT OFFICER · 1 transaction | -2.1% | 60.6K | — | — | 1.3K |
| Slattery Joseph PDirector · 1 transaction | +28.5% | 39.4K | 8.7K | — | — |
| Morrison GregoryCHIEF HUMAN RESOURCES OFFICER · 1 transaction | — | 34.0K | 34.0K | — | — |
| Dale Michael DDirector · 1 transaction | — | 29.0K | 29.0K | — | — |
| Ballinger Kevin J.Director · 1 transaction | — | 8.7K | 8.7K | — | — |
| Hill, Mitch C.Director · 1 transaction | — | 8.7K | 8.7K | — | — |
| Shadan MarthaDirector · 1 transaction | — | 8.7K | 8.7K | — | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over the last 6 months: -16.0K shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.